Cancer protection elicited by a single nucleotide polymorphism close to the adrenomedullin gene

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Martínez Herrero, Sonia ^a   Martínez, Alfredo ^a  

^a CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; DNA;

ADULT; AGED; ALLELE; AM GENE; ARTICLE; BASE MISPAIRING; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENOTYPE; HEART FAILURE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; CYTOPROTECTION; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SPAIN; YOUNG ADULT;

EID: 84876232757     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4193     Document Type: Article

References (20)

1. Lopez J, Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol. 2002; 221:1-92.
2. Zudaire E, Martinez A, Cuttitta F. Adrenomedullin and cancer. Regul Pept. 2003; 112:175-183.
3. Garayoa M, Martinez A, Lee S., et al Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol. 2000; 14:848-862.
4. Miller MJ, Martinez A, Unsworth E.J., et al Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem. 1996; 271:23345-23351.
5. 2-terminal 20 peptide (PAMP) and adrenomedullin bind to tera-tocarcinoma cells. Peptides. 2000; 21:101-107.
6. Martinez A, Vos M, Guedez L., et al The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst. 2002; 94: 1226-1237.
7. 2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res. 2004; 64:6489-6494.
8. Zudaire E, Martinez A, Garayoa M., et al Adrenomedullin isacross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol. 2006; 168:280-291.
9. Ishimitsu T, Hosoya K, Tsukada K., et al Microsatellite DNA polymorphism of human adrenomedullin gene in normotensive subjects and patients with essential hypertension. Hypertension. 2001; 38:9-12.
10. Ishimitsu T, Tsukada K, Minami J., et al Microsatellite DNA polymorphism of human adrenomedullin geneintype2diabetic patients with renal failure. Kidney Int. 2003; 63:2230-2235.
11. Ong KL, Tso AW, Leung R.Y., et al A genetic variant in the gene encoding adrenomedullin predicts the development of dysglycemia over 6.4 years in Chinese. Clin Chim Acta. 2011; 412:353-357.
12. Glubb DM, McHugh PC, Deng X, Joyce P.R., Kennedy MA Association of a functional polymorphism in the adrenomedullin gene (ADM) with response to paroxetine. Pharmacogenomics J. 2010; 10:126-133.
13. Hirose T, Totsune K, Nakashige Y., et al Influence of adrenomedul-lin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese: the Ohasama study. Hypertens Res. 2011; 34:1327-1332.
14. Cheung BM, Ong KL, Tso A.W., et al Plasma adrenomedullin level is relatedtoasingle nucleotide polymorphisminthe adrenomedullin gene. Eur J Endocrinol. 2011; 165:571-577.
15. Ebina M, Martinez A, Birrer M.J., Ilona LR In situ detection of unexpected patterns of mutant p53 gene expressioninnon-small cell lung cancers. Oncogene. 2001; 20:2579-2586.
16. Boyle P, Levin B. World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer, 2008.
17. Tang W, Fu YP, Figueroa J.D., et al Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet. 2012; 21:1918-1930.
18. Zhou J, Nagarkatti PS, Zhong Y, Creek K., Zhang J, Nagarkatti M. Unique SNP in CD44 intron 1 and its role in breast cancer development. Anticancer Res. 2010; 30:1263-1272.
19. Hurtado O, Serrano J, Sobrado M., et al Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model. Neuroscience. 2010; 171:885-892.
20. Garcia-Honduvilla N., Cifuentes A, Bellon J., Bujan J, Martinez A. The angiogenesis promoter, proadrenomedullin N-terminal 20 peptide (PAMP), improves healing in both normoxic and ischemic wounds either alone or in combination with autologous stem/progenitor cells. Histol Histopathol. 2013; 28:115-125.